These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3388474)

  • 1. Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus.
    Ward JW; Kleinman SH; Douglas DK; Grindon AJ; Holmberg SD
    Transfusion; 1988; 28(4):298-301. PubMed ID: 3388474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors. HIV Blood Donor Study Group.
    Petersen LR; Doll LS; White CR; Johnson E; Williams A
    Transfusion; 1993 Jul; 33(7):552-7. PubMed ID: 7687391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1-infected blood donors: epidemiologic, laboratory, and donation characteristics. The HIV Blood Donor Study Group.
    Petersen LR; Doll LS
    Transfusion; 1991 Oct; 31(8):698-703. PubMed ID: 1926312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
    Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
    AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand.
    Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
    Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodologic approaches to surveillance of HIV infection among blood donors.
    Petersen LR; Dodd R; Dondero TJ
    Public Health Rep; 1990; 105(2):153-7. PubMed ID: 2108461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS and prevalence of antibody to human immunodeficiency virus (HIV) in high risk groups in Thailand.
    Traisupa A; Wongba C; Taylor DN
    Genitourin Med; 1987 Apr; 63(2):106-8. PubMed ID: 3646990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus: Thailand.
    Nuchprayoon C; Tanprasert S; Chumnijarakij T; Thanomchat S; O'Prasert B; Adulwijit S
    Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):98-103. PubMed ID: 8525427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human immunodeficiency virus infections (HIV-1 and HIV-2) in Dakar. Epidemiologic and clinical aspects].
    Barabe P; Digoutte JP; Tristan JF; Peghini M; Griffet P; Jean P; Seignot P; Sarthou JL; Leguenno B; Berlioz C
    Med Trop (Mars); 1988; 48(4):337-44. PubMed ID: 3221781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV seroprevalence among healthy blood donors in northeastern Zaire.
    Fischer PR; Horton GL; Knight P; Lusi KM
    Int J STD AIDS; 1991; 2(1):52-3. PubMed ID: 2036462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their regular female partners in northern Thailand.
    Nagachinta T; Duerr A; Suriyanon V; Nantachit N; Rugpao S; Wanapirak C; Srisomboon J; Kamtorn N; Tovanabutra S; Mundee Y; Yutrabutr Y; Kaewvichit R; Rungruèngthanakit K; de Boer M; Tansuhaj A; Flowers L; Khamboonruang C; Celentano DD; Nelson KE
    AIDS; 1997 Nov; 11(14):1765-72. PubMed ID: 9386812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. The HIV Blood Donor Study Group.
    Doll LS; Petersen LR; White CR; Ward JW
    Transfusion; 1991 Oct; 31(8):704-9. PubMed ID: 1926313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural risk factors for acquisition of HIV infection and knowledge about AIDS among male professional blood donors in Delhi.
    Chattopadhya D; Riley LW; Kumari S
    Bull World Health Organ; 1991; 69(3):319-23. PubMed ID: 1893506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood donors seropositive for type 1 human immunodeficiency virus (HIV-1). Epidemiologic characteristics and clinical course].
    Altès A; Muñiz-Díaz E; Madoz P; Verger G; Martino R; Puig L
    Sangre (Barc); 1995 Aug; 40(4):269-74. PubMed ID: 7482114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus antibodies in sera of Australian blood donors: 1985-1990.
    Kaldor J; Whyte B; Archer G; Hay J; Keller A; Kennedy T; Mackenzie I; Pembrey R; Way B; Whyte G
    Med J Aust; 1991 Sep; 155(5):297-300. PubMed ID: 1895970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.
    Petersen LR; Satten GA; Dodd R; Busch M; Kleinman S; Grindon A; Lenes B
    Transfusion; 1994 Apr; 34(4):283-9. PubMed ID: 8178324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of blood donations for HIV-1 antibody: 1985-1991.
    Gunson HH; Rawlinson VI
    CDR (Lond Engl Rev); 1991 Dec; 1(13):R144-6. PubMed ID: 1669759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing blood donor screening criteria from permanent deferral for men who have sex with men to individual sexual risk assessment: no evidence of a significant impact on the human immunodeficiency virus epidemic in Italy.
    Suligoi B; Pupella S; Regine V; Raimondo M; Velati C; Grazzini G
    Blood Transfus; 2013 Jul; 11(3):441-8. PubMed ID: 23867178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.